Clinical trial
SITELINE 2 Polyurethane
NCT00180284 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00180284 |
|---|---|
| Title | SITELINE 2 Polyurethane |
| Official title | SITELINE 2 Polyurethane Clinical Investigation |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bradycardia |
| Intervention type | Device |
| Interventions | SITELINE 2 Polyurethane (pacing lead) |
| Enrollment | 200 |
| Start date | Nov 1, 2004 |
| Primary completion | May 1, 2005 |
| Completion | Feb 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 29, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: